Is Israel's new drug EXO-CD24 the hope of ending the new coronavirus?

Text|Medical big cow cat

Recently, many domestic media have rushed to report that Israeli medical staff have obtained a new drug EXO-CD24 that has a significant effect on the new coronavirus infection

Although the number of clinical trials is limited, the efficacy results are very positive

Previously, the results of clinical trials of the drug showed that 21 patients were tested, and 19 patients showed significant improvement within a few days and were discharged after a week

EXO-CD24 is an immune drug that specifically suppresses cytokine storm

Although the detailed structure of EXO-CD24 is not known, we know that CD24 is involved in the process of autoimmunity in the body's immune response

In the human body, how does the drug achieve its curative effect?

This protein, called CD24, is delivered to the lungs through the exosomes in the drug, which helps to rebalance the immune system and prevent it from overreacting to the virus

If the efficacy of the drug EXO-CD24 can be determined through a large sample of clinical trials, it will bring a great chance of survival to severely ill patients with new coronary infection

EXO-CD24 was originally a targeted anti-cancer drug

EXO-CD24 was originally a targeted anti-cancer drug, and it is reported to be used to treat certain types of cancer

summary

In short, although the number of patients participating in clinical trials of EXO-CD24 is relatively small, the existing results show very positive clinical effects